DVL ASX · Health Care

Dorsavi Ltd

Announcements, last 12 months: 80
Price sensitive, last 12 months: 36
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
23 Oct 2026, 4:58 PM	Section 708A Cleansing Notice
23 Oct 2026, 4:52 PM	Notification regarding unquoted securities - DVL
23 Oct 2026, 4:51 PM	Notification regarding unquoted securities - DVL
23 Oct 2026, 4:49 PM	Application for quotation of securities - DVL
23 Oct 2026, 4:49 PM	Notification regarding unquoted securities - DVL
23 Oct 2026, 4:43 PM	Application for quotation of securities - DVL
23 Oct 2026, 9:44 AM	Quarterly Activities/Appendix 4C Cash Flow Report Price sensitive	AI summary
12 Oct 2026, 4:39 PM	Annual General Meeting
6 Oct 2026, 9:07 AM	Proposed issue of securities - DVL
6 Oct 2026, 9:06 AM	Proposed issue of securities - DVL

Sign in to see all DVL announcements.

Guidance history

4 Jun 2026	Dorsavi expects a battery-life improvement of more than 2x with RRAM-neuromorphic technology.
18 May 2026	Tape-out targeted for Q3 2026, 22nm design phase in H2 2027
30 Apr 2026	The 22-nm RRAM program targets lower write voltage, reduced latency, improved reliability, and support for compute-in-memory operation relative to the current 40-nm RRAM devices. These improvements are intended to deliver higher performance per watt and more efficient AI and neuromorphic processing in power- and latency-constrained ultra edge applications, including robotics, drones, and autonomous platforms.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow DVL to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.